NFKB1 and bronchiectasis: Since it has been proven that SIRT-1 can affect inflammatory pathways by inhibiting NF-κB activity, it can be concluded that decreased SIRT-1 activity and high MMP-9 levels are associated with increased inflammatory conditions in bronchiectasis patients.